Carbylan Therapeutics Announces Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Carbylan Therapeutics (CBYL) Misses Q2 EPS by 16c
August 11, 2015 4:16 PM EDTCarbylan Therapeutics (NASDAQ: CBYL) reported Q2 EPS of ($0.37), $0.16 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Carbylan Therapeutics (CBYL) click here.
... More